Unknown

Dataset Information

0

Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study.


ABSTRACT:

Objective

Osteoporotic fragility fractures, that are common in men and women, signal increased risk of future fractures and of premature mortality. Less than one-third of postmenopausal women and fewer men are prescribed active treatments to reduce fracture risk. Therefore, in this study the association of oral bisphosphonate recommendation with subsequent fracture and mortality over eight years in a fracture liaison service setting was analysed.

Materials and methods

In this prospective cohort study, 5011 men and women aged >50 years, who sustained a clinical fracture, accepted the invitation to attend the fracture liaison service of the West Glasgow health service between 1999 and 2007. These patients were fully assessed and all were recommended calcium and vitamin D. Based on pre-defined fracture risk criteria, 2534 (50.7%) patients were additionally also recommended oral bisphosphonates. Mortality and subsequent fracture risk were the pre-defined outcomes analysed using Cox proportional hazard models.

Results

Those recommended bisphosphonates were more often female (82.9 vs. 72.4%), were older (73.4 vs. 64.4 years), had lower bone mineral density T-score (-3.1 vs. -1.5) and more had sustained hip fractures (21.7 vs. 6.2%; p < 0.001). After adjustments, patients recommended bisphosphonates had lower subsequent fracture risk (Hazard Ratio (HR): 0.60; 95% confidence interval (CI): 0.49-0.73) and lower mortality risk (HR: 0.79, 95%CI: 0.64-0.97).

Conclusion

Of the patients, who are fully assessed after a fracture at the fracture liaison service, those with higher fracture risk and a recommendation for bisphosphonates had worse baseline characteristics. However, after adjusting for these differences, those recommended bisphosphonate treatment had a substantially lower risk for subsequent fragility fracture and lower risk for mortality. These community-based data indicate the adverse public health outcomes and mortality impacts of the current low treatment levels post fracture could be improved by bisphosphonate recommendation for both subsequent fracture and mortality.

SUBMITTER: van Geel TACM 

PROVIDER: S-EPMC5983426 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study.

van Geel Tineke A C M TACM   Bliuc Dana D   Geusens Piet P M PPM   Center Jacqueline R JR   Dinant Geert-Jan GJ   Tran Thach T   van den Bergh Joop P W JPW   McLellan Alastair R AR   Eisman John A JA  

PloS one 20180601 6


<h4>Objective</h4>Osteoporotic fragility fractures, that are common in men and women, signal increased risk of future fractures and of premature mortality. Less than one-third of postmenopausal women and fewer men are prescribed active treatments to reduce fracture risk. Therefore, in this study the association of oral bisphosphonate recommendation with subsequent fracture and mortality over eight years in a fracture liaison service setting was analysed.<h4>Materials and methods</h4>In this pros  ...[more]

Similar Datasets

| S-EPMC9826296 | biostudies-literature
| S-EPMC6324344 | biostudies-literature
| S-EPMC8376729 | biostudies-literature
| S-EPMC5818578 | biostudies-literature
| S-EPMC6339551 | biostudies-literature
| S-EPMC5544781 | biostudies-other
| S-EPMC4740567 | biostudies-literature
| S-EPMC7223766 | biostudies-literature
| S-EPMC4776625 | biostudies-literature
| S-EPMC5321497 | biostudies-literature